
Oman posts strong gains in food self-sufficiency
According to the Oman Investment Authority (OIA), a key government entity mandated to strengthen food security among other objectives, the GDP contribution of the agriculture, fisheries and forestry sectors grew by 9.8 per cent year-on-year, reaching RO 966.4 million in 2023. By the end of the first half of 2024, the figure stood at RO 529.5 million, underscoring the significant pace of growth in the country's broader food economy.
Oman Food Capital, the new brand established following the merger of OIA subsidiaries Oman Food Investment Holding Company (Nitaj) and Fisheries Development Oman (FDO), currently oversees investments and assets valued at over RO 1 billion.
Its portfolio spans the entire food value chain, including fisheries, aquaculture, poultry and red meat production, dairy, fruits and vegetables, animal feed, food processing, agri-tech and R&D, logistics and cold chain infrastructure and local farming.
These investments, coupled with initiatives by the Ministry of Agriculture, Fisheries and Water Resources to stimulate sector-wide growth, have contributed to a significant uptick in food self-sufficiency ratios across key food categories.
According to data compiled by Oxford Business Group on behalf of the OIA, Oman recorded notable shifts in its food self-reliance indicators in 2024 compared to the previous year. Fish remained the most self-sufficient food category, improving from 151 per cent in 2023 to 162 per cent in 2024, highlighting Oman's robust marine production and growing export potential. Fresh milk also saw a strong performance, rising from 88 per cent to 97 per cent signalling improvements in domestic dairy output and supply chain efficiency.
Table eggs experienced a dramatic increase in self-sufficiency, jumping from 59 per cent in 2023 to 92 per cent in 2024, thanks to expanded poultry farming capacity and improved production practices. Fruit production more than doubled in performance, rising from 26 per cent to 57 per cent, indicating broader cultivation and improved seasonal yields. Red meat saw a modest increase from 44 per cent to 46 per cent, reflecting incremental gains in livestock production.
Conversely, a few food categories saw declines. Vegetable self-sufficiency dropped from 77 per cent in 2023 to 60 per cent in 2024, while poultry experienced a modest decline from 61 per cent to 55 per cent.
Nonetheless, Oman continues to strengthen its agricultural and food sectors through strategic investment. The Oxford Business Group report noted that the Sultanate of Oman is leveraging technology and capital to enhance productivity across its 1.4 million hectares of agricultural land, thereby reinforcing food security and economic resilience.
'By 2024, the country achieved self-sufficiency rates of 92 per cent in table eggs, 97 per cent in fresh milk and 162 per cent in fish production — reflecting considerable progress in fundamental segments', the report stated.
The fisheries sector in particular has been described as a 'pillar of economic diversification', with production reaching 748,000 tonnes in 2022, valued at $1.2 billion. Exports rose by 23.7 per cent in the previous year to $362 million, positioning Oman as a global leader in sustainable aquaculture, the report added.
In 2024, Oman launched 89 new investment projects in agriculture and fisheries, covering over 9 million square metres. These include 70 agricultural ventures, 10 livestock projects, seven water-related initiatives and two fisheries projects, all aimed at enhancing food security through modern scientific methods. The projects require a minimum 30 per cent Omani or GCC ownership, aligning with Oman's broader strategy to boost private sector participation and sustainable sectoral growth.
By 2025, the sector aims to attract $1.2 billion in investment and generate 8,500 jobs. Notable initiatives include integrated aquaculture farms and artisanal fishery projects, supported by Oman's strategic geographic location and robust logistics infrastructure — further reinforcing the Sultanate of Oman's emerging role as a regional food distribution hub, the report concluded.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Khaleej Times
16 minutes ago
- Khaleej Times
UAE Central Bank revokes licence of Al Nahdi Exchange
The Central Bank of the UAE (CBUAE) has revoked the licence of Al Nahdi Exchange, an Exchange House operating in the UAE, and struck its name off the Register, pursuant to Article (137) of the Decretal Federal Law No. (14) of 2018 Regarding the Central Bank and Organisation of Financial Institutions and Activities, and its amendments. The licence revocation was based on the CBUAE's examination findings, which revealed significant failures by the Exchange House to comply with the Anti-Money Laundering, Combating the Financing of Terrorism and Illegal Organisations, and Sanctions framework. The CBUAE, through its supervisory and regulatory mandates, endeavours to ensure that all exchange houses, their owners, and staff comply with the UAE laws, regulations and standards established by the CBUAE to maintain transparency and integrity of the exchange houses industry and safeguard the UAE financial ecosystem.


Zawya
16 minutes ago
- Zawya
New agreement brings breakthrough dyslipidemia treatment to Saudi Arabia and MEA
JEDDAH – Jamjoom Pharma, a leading Saudi pharmaceutical organization committed to enhancing the quality of life through the development, manufacturing, and distribution of high-quality medicines and consumer healthcare products across MEA, and Althera Laboratories, a company dedicated to developing and commercializing innovative therapies for cardiovascular and metabolic diseases, today announced a strategic licensing and supply agreement. This agreement is poised to address the growing need for effective dyslipidemia management in the region, contributing to better patient outcomes and cardiovascular health. Under this agreement, Jamjoom Pharma gets exclusive rights to commercialize in Saudi Arabia and non-exclusive rights for phased expansion across other MEA markets for Althera's fixed-dose combination of dual-action cholesterol-lowering therapy. The product launch in Saudi Arabia is targeted for 2027, with plans for phased expansion across MEA markets, subject to local regulatory approvals. This collaboration marks a major milestone for both companies: Jamjoom strengthens its cardiovascular portfolio with a globally recognized and clinically effective therapy, while Althera expands its international footprint in a high-growth region. The partnership aims to address the region's growing burden of cardiovascular diseases by increasing access to modern, affordable lipid-lowering treatment, to support patients across MEA. Dr. Tarek Hosni, CEO of Jamjoom Pharma, highlighted that: 'Cardiovascular diseases remain to be a leading health concern in Saudi Arabia and the wider MEA region, and this partnership enables us to provide patients across the MEA region with an innovative, evidence-based solution. Expanding access to effective cholesterol management aligns perfectly with our promise to deliver high-quality, affordable medications that improve lives.' Sanjeev Agarwal, CEO of Althera added " This partnership with Jamjoom Pharma is a pivotal step for Althera, allowing us to extend our reach into the rapidly growing MENA region. We are confident that Jamjoom's deep market understanding and robust capabilities make them the perfect partner to deliver our Rproduct to healthcare providers and patients in Saudi Arabia and across MENA. This collaboration is a testament to our dedication to making innovative and affordable cardiovascular treatments more accessible globally." About Althera: Founded in 2010, Althera focuses on developing, out-licensing, manufacturing and supplying high value branded and select complex generic medicines. Althera pioneers innovative value added combinations fostering benefits throughout the value chain resulting in benefits for our partners, payers, prescribers and patients particularly in heart disease, diabetes and obesity management. Althera is headquartered in Dublin, Ireland. About Jamjoom Pharma 'Jamjoom Pharmaceuticals Factory Company': Jamjoom Pharma is a leading pharmaceutical organization committed to enhancing the quality of life through the development, manufacturing, and distribution of high-quality medicines and consumer healthcare products. Headquartered in Saudi Arabia, the company was established back in 2000 and is tirelessly operating to support the Saudi Vision 2030 to reinforce the public healthcare system. With a strong focus on patient-centered care, Jamjoom Pharma serves diverse markets across Middle East & Africa, with a bold ambition for more expansion, providing effective solutions in key therapeutic areas (including ophthalmology, dermatology, cardiometabolic, gastrointestinal, and general medicine). Through its state-of-the-art facilities and established distribution channels across the MEA region and dedication to regulatory excellence, Jamjoom Pharma continues to deliver products that meet the highest standards of safety, efficacy, and quality, improving health outcomes for millions of people.


Zawya
16 minutes ago
- Zawya
CBUAE revokes licence of Al Nahdi Exchange
Abu Dhabi: The Central Bank of the UAE (CBUAE) has revoked the licence of Al Nahdi Exchange, an Exchange House operating in the UAE, and struck its name off the Register, pursuant to Article (137) of the Decretal Federal Law No. (14) of 2018 Regarding the Central Bank and Organization of Financial Institutions and Activities, and its amendments. The licence revocation was imposed based on the results of the findings of examinations conducted by the CBUAE, which revealed that the Exchange House had significant failures to comply with the Anti-Money Laundering and Combating the Financing of Terrorism and Illegal Organisations and Sanctions framework. The CBUAE, through its supervisory and regulatory mandates, endeavours to ensure that all exchange houses, their owners, and staff comply with the UAE laws, regulations and standards established by the CBUAE to maintain transparency and integrity of the exchange houses industry and safeguard the UAE financial ecosystem.